Literature DB >> 10531253

Human onchocerciasis and tetanus vaccination: impact on the postvaccination antitetanus antibody response.

P J Cooper1, I Espinel, M Wieseman, W Paredes, M Espinel, R H Guderian, T B Nutman.   

Abstract

To investigate whether helminth infections may affect the efficacy of vaccines by impairing the immune response to nonparasite vaccine antigens, we compared the antibody responses to tetanus toxoid (TT) after tetanus vaccination in 193 subjects with Onchocerca volvulus infection with 85 comparable noninfected controls. After vaccination, the proportions of subjects in each group attaining protective levels of antitetanus antibodies were similar (96.9% infected versus 97.6% noninfected). Postvaccination increases in antitetanus immunoglobulin G (IgG) and the predominant IgG isotype, IgG1, were equivalent in both groups, as were increases in specific IgG4 and IgE; however, significantly greater increases in specific IgG2 (P < 0.05) and IgG3 (P < 0.001) were observed in the noninfected group. Stratification of the O. volvulus-infected group into two groups representing light and heavy infections revealed a significantly impaired antitetanus IgG response in those with heavy infections compared to those with light infections (P < 0.01) or no infection (P < 0.05). The impact of concurrent intestinal helminth infections on the antitetanus response was also examined; an increased IgG4/IgE ratio was seen in those infected with Strongyloides stercoralis (P < 0.05) and when all helminth infections were combined as a single group (P < 0.05). These findings indicate that concurrent infection with O. volvulus does not prevent the development of a protective antitetanus response, although heavier O. volvulus infections are able to alter the magnitude of this response, and concurrent helminth infections (O. volvulus and intestinal helminths) may alter TT-specific antibody isotype responses.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10531253      PMCID: PMC96979     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

1.  [Ultrastructural aspects of the degeneration of the dermal microfilaria O. volvulus under the effect of diethylcarbamazine in human onchocerciasis].

Authors:  A Rougemont; X Mattei; C Discamps; E Loreal; N Zander; J R Mazelet
Journal:  C R Seances Soc Biol Fil       Date:  1978

2.  The fall-off in serum concentration of tetanus antitoxin after primary and booster vaccination.

Authors:  O Simonsen; J H Badsberg; K Kjeldsen; B Møller-Madsen; I Heron
Journal:  Acta Pathol Microbiol Immunol Scand C       Date:  1986-04

3.  Immunosuppression in children with malaria.

Authors:  B M Greenwood; A M Bradley-Moore; A D Bryceson; A Palit
Journal:  Lancet       Date:  1972-01-22       Impact factor: 79.321

4.  Naturally occurring blocking antibodies modulate immediate hypersensitivity responses in human filariasis.

Authors:  E A Ottesen; V Kumaraswami; R Paranjape; R W Poindexter; S P Tripathy
Journal:  J Immunol       Date:  1981-11       Impact factor: 5.422

Review 5.  Cell-mediated damage to helminths.

Authors:  A E Butterworth
Journal:  Adv Parasitol       Date:  1984       Impact factor: 3.870

6.  Use of monoclonal antibodies to quantify subclasses of human IgG. II. Enzyme immunoassay to define antigen specific (anti-filarial) IgG subclass antibodies.

Authors:  R Hussain; R W Poindexter; E A Ottesen; C B Reimer
Journal:  J Immunol Methods       Date:  1986-11-20       Impact factor: 2.303

7.  Circulating immune complexes and their possible relevance to other immunological parameters in Guatemalan onchocerciasis.

Authors:  M Kawabata; S Izui; S Anan; S Kondo; S Fukumoto; G Z Flores; T Kobayakawa
Journal:  Int Arch Allergy Appl Immunol       Date:  1983

8.  Impaired tetanus-specific cellular and humoral responses following tetanus vaccination in human onchocerciasis: a possible role for interleukin-10.

Authors:  P J Cooper; I Espinel; W Paredes; R H Guderian; T B Nutman
Journal:  J Infect Dis       Date:  1998-10       Impact factor: 5.226

9.  Response to tetanus immunization in onchocerciasis patients.

Authors:  A Prost; M Schlumberger; M T Fayet
Journal:  Ann Trop Med Parasitol       Date:  1983-02

10.  Immunogenicity of hepatitis B vaccine in patients infected with Schistosoma mansoni.

Authors:  S Bassily; K C Hyams; N M el-Ghorab; M M Mansour; N A el-Masry; M A Dunn
Journal:  Am J Trop Med Hyg       Date:  1987-05       Impact factor: 2.345

View more
  27 in total

1.  Previous or ongoing schistosome infections do not compromise the efficacy of the attenuated cercaria vaccine.

Authors:  Thomas M Kariuki; Govert J Van Dam; André M Deelder; Idle O Farah; Dorcas S Yole; R Alan Wilson; Patricia S Coulson
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

2.  Children with retinopathy-negative cerebral malaria: a pathophysiologic puzzle.

Authors:  Douglas G Postels; Gretchen L Birbeck
Journal:  Pediatr Infect Dis J       Date:  2011-11       Impact factor: 2.129

Review 3.  Human innate lymphoid cells (ILCs) in filarial infections.

Authors:  S Bonne-Année; T B Nutman
Journal:  Parasite Immunol       Date:  2017-06-15       Impact factor: 2.280

4.  Helminth infection alters IgE responses to allergens structurally related to parasite proteins.

Authors:  Helton da Costa Santiago; Flávia L Ribeiro-Gomes; Sasisekhar Bennuru; Thomas B Nutman
Journal:  J Immunol       Date:  2014-11-17       Impact factor: 5.422

5.  Prolonged infection by Fonsecaea pedrosoi after antigenic co-stimulation at different sites in experimental murine chromoblastomycosis.

Authors:  Alexandre Paulo Machado; Maria Regina Regis Silva; Olga Fischman
Journal:  Virulence       Date:  2010 Jan-Feb       Impact factor: 5.882

6.  Impairment of protective immunity to blood-stage malaria by concurrent nematode infection.

Authors:  Zhong Su; Mariela Segura; Kenneth Morgan; J Concepcion Loredo-Osti; Mary M Stevenson
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

Review 7.  Malaria and helminth interactions in humans: an epidemiological viewpoint.

Authors:  T W Mwangi; J M Bethony; S Brooker
Journal:  Ann Trop Med Parasitol       Date:  2006-10

Review 8.  Human Helminths and Allergic Disease: The Hygiene Hypothesis and Beyond.

Authors:  Helton C Santiago; Thomas B Nutman
Journal:  Am J Trop Med Hyg       Date:  2016-08-29       Impact factor: 2.345

9.  Impairment of tetanus-specific cellular and humoral responses following tetanus vaccination in human lymphatic filariasis.

Authors:  Suba Nookala; Sundaram Srinivasan; Perumal Kaliraj; Rangarajan Badri Narayanan; Thomas B Nutman
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

10.  Elimination of helminth infection restores HIV-1C vaccine-specific T cell responses independent of helminth-induced IL-10.

Authors:  Akram A Da'dara; Donald A Harn
Journal:  Vaccine       Date:  2009-11-24       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.